dm300
Generic: recombinant human ulinastatin
dm300: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | Phase 2/Phase 3 |
Get deeper analysis on dm300
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis